These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26260711)

  • 21. Ketoacidosis at diagnosis of type 1 diabetes in French children and adolescents.
    Choleau C; Maitre J; Filipovic Pierucci A; Elie C; Barat P; Bertrand AM; de Kerdanet M; Letallec C; Levy-Marchal C; Nicolino M; Tubiana-Rufi N; Cahané M; Robert JJ;
    Diabetes Metab; 2014 Apr; 40(2):137-42. PubMed ID: 24332018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic inertia: underdiagnosed and undertreated hypertension in children participating in the T1D Exchange Clinic Registry.
    Nambam B; DuBose SN; Nathan BM; Beck RW; Maahs DM; Wadwa RP; Tamborlane WV; Foster NC; Miller KM; Haller MJ;
    Pediatr Diabetes; 2016 Feb; 17(1):15-20. PubMed ID: 25330905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrovascular angiopathy in children and adolescents with type 1 diabetes.
    Giannini C; Mohn A; Chiarelli F; Kelnar CJ
    Diabetes Metab Res Rev; 2011 Jul; 27(5):436-60. PubMed ID: 21433262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and Mortality Rates and Clinical Characteristics of Type 1 Diabetes among Children and Young Adults in Cochabamba, Bolivia.
    Duarte Gómez E; Gregory GA; Castrati Nostas M; Middlehurst AC; Jenkins AJ; Ogle GD
    J Diabetes Res; 2017; 2017():8454757. PubMed ID: 28948172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of type 1 diabetes in Polish children: A multicentre cohort study.
    Szalecki M; Wysocka-Mincewicz M; Ramotowska A; Mazur A; Lisowicz L; Beń-Skowronek I; Sieniawska J; Klonowska B; Charemska D; Nawrotek J; Jałowiec I; Bossowski A; Jamiołkowska M; Pyrżak B; Miszkurka G; Szypowska A
    Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29144024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
    Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
    Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prevalence of Dyslipidemia and Other Cardiovascular Risk Factors in Youth with Diabetes.
    Hamilton L; Wilson DP; O'Reilly CM; Gonzalez J; de la Torre A
    Curr Pediatr Rev; 2017; 13(4):277-280. PubMed ID: 29473517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular drug use and hospitalizations attributable to type 2 diabetes.
    Erkens JA; Klungel OH; Stolk RP; Spoelstra JA; Grobbee DE; Leufkens HG
    Diabetes Care; 2001 Aug; 24(8):1428-32. PubMed ID: 11473081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of obesity and type 1 diabetes on renal function in children and adolescents.
    Franchini S; Savino A; Marcovecchio ML; Tumini S; Chiarelli F; Mohn A
    Pediatr Diabetes; 2015 Sep; 16(6):427-33. PubMed ID: 25131409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland.
    Tuomilehto J; Borch-Johnsen K; Molarius A; Forsén T; Rastenyte D; Sarti C; Reunanen A
    Diabetologia; 1998 Jul; 41(7):784-90. PubMed ID: 9686919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National prescribing trends for heart failure medications in children.
    Moffett BS; Price JF
    Congenit Heart Dis; 2015; 10(1):78-85. PubMed ID: 24725766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secular trends of body mass index in North Indian children with Type 1 diabetes do not support the Accelerator Hypothesis.
    Dayal D; Samprathi M; Jayaraman D; Kohat D; Bhalla AK
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):338-41. PubMed ID: 26342175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case-crossover study of infectious diseases and new diagnosis of type 1 diabetes.
    Shoshan A; Sella T; Shohat T; Goren I; Shalev V; Chodick G
    Pediatr Diabetes; 2012 Nov; 13(7):583-6. PubMed ID: 22765293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 1 diabetes in children and adolescents is not associated with a reduced prevalence of atopy and allergic diseases.
    Jasser-Nitsche H; Varga EM; Borkenstein HM; Höntzsch J; Suppan E; Weinhandl G; Pieringer L; Avian A; Fröhlich-Reiterer E
    Pediatr Diabetes; 2017 Dec; 18(8):890-894. PubMed ID: 28239959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the incidence of type 1 diabetes in children and adolescents stabilising? The first 6 years of a National Register.
    Roche EF; McKenna AM; Ryder KJ; Brennan AA; O'Regan M; Hoey HM
    Eur J Pediatr; 2016 Dec; 175(12):1913-1919. PubMed ID: 27659662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of cardiovascular risk among patients with type 1 diabetes: A critical analysis of the metabolic syndrome and its components.
    Gingras V; Leroux C; Fortin A; Legault L; Rabasa-Lhoret R
    Diabetes Metab; 2017 Jun; 43(3):217-222. PubMed ID: 28139436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initiation and Single Dispensing in Cardiovascular and Insulin Medications: Prevalence and Explanatory Factors.
    Vilaplana-Carnerero C; Aznar-Lou I; Peñarrubia-María MT; Serrano-Blanco A; Fernández-Vergel R; Petitbò-Antúnez D; Gil-Girbau M; March-Pujol M; Mendive JM; Sánchez-Viñas A; Carbonell-Duacastella C; Rubio-Valera M
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32408626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of drugs related to the treatment of diabetes mellitus and other cardiovascular risk factors in the Spanish population. The Di@bet.es study.
    Rojo-Martínez G; Valdés S; Colomo N; Lucena MI; Gaztambide S; Gomis R; Casamitjana R; Carmena R; Catalá M; Martínez-Larrad MT; Serrano-Ríos M; Castaño L; Vendrell J; Girbés J; Franch J; Vázquez JA; Mora-Peces I; Urrutia I; Pascual-Manich G; Ortega E; Menéndez E; Delgado E; Bordiú E; Castell C; López-Alba A; Goday A; Calle A; Bosch-Comas A; Soriguer F
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):854-63. PubMed ID: 24773992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain].
    Ortega E; Amor AJ; Rojo-Martínez G; Castell C; Giménez M; Conget I
    Med Clin (Barc); 2015 Sep; 145(6):233-8. PubMed ID: 25561182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study.
    Wakkee M; Meijer W; Neumann HA; Herings RM; Nijsten T
    Acta Derm Venereol; 2009; 89(5):476-83. PubMed ID: 19734972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.